1. Home
  2. RBCAA vs ANAB Comparison

RBCAA vs ANAB Comparison

Compare RBCAA & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

N/A

Current Price

$84.60

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

ANAB

AnaptysBio Inc.

N/A

Current Price

$51.14

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RBCAA
ANAB
Founded
1974
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
RBCAA
ANAB
Price
$84.60
$51.14
Analyst Decision
Hold
Buy
Analyst Count
1
12
Target Price
N/A
$71.67
AVG Volume (30 Days)
61.1K
516.0K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
2.41%
N/A
EPS Growth
N/A
91.02
EPS
0.77
N/A
Revenue
$417,495,000.00
$234,603,000.00
Revenue This Year
$3.93
N/A
Revenue Next Year
N/A
$52.14
P/E Ratio
$109.74
N/A
Revenue Growth
8.50
157.01
52 Week Low
$63.97
$17.11
52 Week High
$85.58
$73.30

Technical Indicators

Market Signals
Indicator
RBCAA
ANAB
Relative Strength Index (RSI) 69.05 32.75
Support Level $67.07 $43.75
Resistance Level N/A $51.67
Average True Range (ATR) 1.88 2.44
MACD 0.41 -0.88
Stochastic Oscillator 85.76 8.42

Price Performance

Historical Comparison
RBCAA
ANAB

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: